Revista brasileira de parasitologia veterinaria = Brazilian journal of veterinary parasitology : Orgao Oficial do Colegio Brasileiro de Parasitologia Veterinaria · 2026
Efficacy of selenium- and tellurium-based organocompounds against ruminant gastrointestinal nematodes in vitro.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Piano Taynara Gabriele Ribeiro, Romero Neto Irineu, Piovan Leandro, Oliveira Leandro Bittencourt de, Monteiro Alda Lúcia Gomes, Zugman Tay, Zotz Bernardo Ariel Schorr, Yoshitani Ursula Yaeko, Molento Marcelo Beltrão
Аннотация
Gastrointestinal nematode (GIN) infections significantly impact the health of ruminants. The indiscriminate use of anthelmintics contributes to the selection of drug-resistant parasites. Compounds containing selenium (Se) and tellurium (Te) have emerged as promising alternatives. This study aimed to evaluate the anthelmintic activity of diphenyl diselenide (PhSe)2, phenylselenenyl chloride (4-Cl-PhSe)2, and ammonium trichloro (dioxoethylene-O,O') tellurate (AS-101) on eggs and larvae (L3) of GIN. The compounds were tested using egg-hatch and larval-migration inhibition tests. Additionally, the possible in vitro cytotoxic effects were evaluated using the AlamarBlue assay. (PhSe)2 exhibited the highest ovicidal effect, with a 50% inhibitory concentration (IC50) of 1.801 mmol L-1 for GIN isolated from sheep and 1.845 mmol L-1 for GIN from cattle. AS-101 showed the highest larvicidal activity, with IC50 values of 0.976 mmol L-1 for GIN of sheep and 1.035 mmol L-1 for GIN of cattle. Combinations of (PhSe)2 with ivermectin (IVM) showed a mild synergistic effect, with an additive interaction of 13.33%. Among the tested compounds, (PhSe)2 showed the lowest cytotoxicity in LLC-MK2 cells. Taken together, these data highlight the therapeutic potential of the novel molecules.